Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06920225 · ClinicalTrials.gov registry record · NA
Transmeridian Travel in Elite Female Athletes
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT06920225: Completed NA study, sponsored by Florida State University.
NCT06920225 is a NA study that has completed, run by Florida State University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06920225, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The study will investigate whether maintaining a home-based time zone schedule will attenuate any decrements to sleep and performance experienced following transmeridian travel in elite female athletes.
Primary Outcome
Sleep duration will be assessed via wrist-worn WHOOP bands.
Interventions
- BEHAVIORAL Maintain home-based schedule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2025-02-15 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
What the finished NCT06920225 record still lists
NCT06920225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Maintain home-based schedule is the first listed.
NCT06920225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06920225 about?
NCT06920225 is a clinical study titled "Transmeridian Travel in Elite Female Athletes". The study will investigate whether maintaining a home-based time zone schedule will attenuate any decrements to sleep and performance experienced following transmeridian travel in elite female athletes.
What is the current status of trial NCT06920225?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2025-02-15. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT06920225?
The interventions under investigation include: Maintain home-based schedule (BEHAVIORAL).
Who is sponsoring clinical trial NCT06920225?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06920225's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI